Company / Current Liabilities per Share
Eton Pharmaceuticals, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.50
FY2025
5-year range
$0.19 / $1.50
FY2021-FY2025
Trend
+90.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has increased for 4 consecutive years, from $0.19 in FY2021 to $1.50 in FY2025.
Based on SEC 10-K filings.
1.50 in FY2025 with a 5-year CAGR of +47.8%.
Increased from $0.67 to $1.50 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +78.7%
- 5-Year CAGR
- +47.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 90.4% year-over-year.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | +90.4% |
| FY2024 | $0.79 | +17.8% |
| FY2023 | $0.67 | +154.6% |
| FY2022 | $0.26 | +39.9% |
| FY2021 | $0.19 | -11.7% |
| FY2020 | $0.21 | +90.4% |
| FY2019 | $0.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026